Paolo Fiorina

Paolo Fiorina

Harvard University

H-index: 62

North America-United States

About Paolo Fiorina

Paolo Fiorina, With an exceptional h-index of 62 and a recent h-index of 36 (since 2020), a distinguished researcher at Harvard University, specializes in the field of MEDICINE-DIABETES.

His recent articles reflect a diverse array of research interests and contributions to the field:

Hyperglycemia impairs EAAT2 glutamate transporter trafficking and glutamate clearance in islets of Langerhans: implications for type 2 diabetes pathogenesis

A multi-omics integration approach relying on circulating factors does not discern endotypes in childhood type 1 diabetes.

Early lung diffusion abnormalities and airways’ inflammation in children with type 1 diabetes

Methods and compositions for treating multiple sclerosis

Treatment of type 1 diabetes and autoimmune diseases or disorders

TMEM219 regulates the transcription factor expression and proliferation of beta cells

P171 Rescuing Intestinal Stem Cells via TMEM219 inhibition promotes mucosal healing in Crohn’s disease

Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide

Paolo Fiorina Information

University

Position

Università degli Studi di Milano-Boston Children's Hospital-Harvard Medical School

Citations(all)

13744

Citations(since 2020)

7126

Cited By

8208

hIndex(all)

62

hIndex(since 2020)

36

i10Index(all)

173

i10Index(since 2020)

119

Email

University Profile Page

Google Scholar

Paolo Fiorina Skills & Research Interests

MEDICINE-DIABETES

Top articles of Paolo Fiorina

Hyperglycemia impairs EAAT2 glutamate transporter trafficking and glutamate clearance in islets of Langerhans: implications for type 2 diabetes pathogenesis

American Journal of Physiology-Endocrinology and Metabolism

2024/5/1

A multi-omics integration approach relying on circulating factors does not discern endotypes in childhood type 1 diabetes.

2024/4/18

Early lung diffusion abnormalities and airways’ inflammation in children with type 1 diabetes

Acta Diabetologica

2024/3

Methods and compositions for treating multiple sclerosis

2020/7/7

Treatment of type 1 diabetes and autoimmune diseases or disorders

2024/1/23

TMEM219 regulates the transcription factor expression and proliferation of beta cells

Frontiers in Endocrinology

2024/1/22

P171 Rescuing Intestinal Stem Cells via TMEM219 inhibition promotes mucosal healing in Crohn’s disease

Journal of Crohn's and Colitis

2024/1/1

Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide

Pharmacological Research

2024/1/1

Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease

2023/4/1

Igfbp3 antibodies and therapeutic uses thereof

2023/2/9

Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01)

Frontiers in Endocrinology

2023/1/18

Giuseppe Favacchio
Giuseppe Favacchio

H-Index: 4

Paolo Fiorina
Paolo Fiorina

H-Index: 32

Cells with increased immuno-regulatory properties and methods for their use and manufacture

2023/1/5

Daytime hypoglycemic episodes during the use of an advanced hybrid closed loop system

Diabetes Research and Clinical Practice

2023/12/1

The anti-inflammatory and immunological properties of SGLT-2 inhibitors

2022/8/1

Mechanisms of action of incretin receptor based dual-and tri-agonists in pancreatic islets

2023/11/1

Reversal of experimental autoimmune diabetes with an sCD39/anti-CD3 treatment

Diabetes

2023/11/1

Pd-l1 expressing hematopoietic stem cells and uses

2023/10/12

Long-term activity and safety of a low-dose hydrocortisone tear substitute in patients with dry eye disease

Current Eye Research

2023/9/2

Cristian Loretelli
Cristian Loretelli

H-Index: 13

Paolo Fiorina
Paolo Fiorina

H-Index: 32

See List of Professors in Paolo Fiorina University(Harvard University)

Co-Authors

academic-engine